Home » Stocks » EMBI

Emerald Bioscience Inc. (EMBI)

Stock Price: $0.0311 USD -0.0019 (-5.76%)
Updated November 27, 12:57 PM EST - Market closed

Stock Price Chart

Key Info

Market Cap 7.78M
Revenue (ttm) n/a
Net Income (ttm) -206,540
Shares Out 250.07M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day November 27
Last Price $0.0311
Previous Close $0.0330
Change ($) -0.0019
Change (%) -5.76%
Day's Open 0.0318
Day's Range 0.0310 - 0.0330
Day's Volume 453,906
52-Week Range 0.031 - 0.245

More Stats

Market Cap 7.78M
Enterprise Value 4.90M
Earnings Date (est) Jan 1, 1970
Ex-Dividend Date n/a
Shares Outstanding 250.07M
Float n/a
EPS (basic) 0.01
EPS (diluted) -0.04
FCF / Share -0.02
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta 0.56
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 4.56
Revenue n/a
Operating Income -6.81M
Net Income -206,540
Free Cash Flow -5.77M
Net Cash 2.87M
Net Cash / Share 0.01
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -140.21%
ROE n/a
ROIC -119.90%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$2.00*
Low
2.00
Current: $0.0311
High
2.00
Target: 2.00
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015201420132012
Revenue-------0.02
Gross Profit-------0.01
Operating Income-6.63-4.69-3.86-4.47-4.32-2.73-0.12-
Net Income1.05-19.19-3.09-3.18-4.84-2.73-0.12-
Shares Outstanding13512127.9118.9516.9410.297.772.33
Earnings Per Share-0.05-0.16-0.11-0.17-0.29-0.27-0.02-
Operating Cash Flow-6.03-3.94-3.33-3.55-3.73-1.76--
Capital Expenditures---0.02-0.01--0.02--
Free Cash Flow-6.03-3.95-3.35-3.56-3.73-1.78--
Cash & Equivalents1.831.860.260.103.260.21-0.03
Total Debt0.391.360.24-----
Net Cash / Debt1.450.500.030.103.260.21-0.03
Assets2.001.960.560.323.510.35-0.04
Liabilities1.4517.521.361.773.040.800.18-
Book Value0.55-15.56-3.57-2.91-0.89-0.45-0.180.04
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Emerald Bioscience Inc.
Country United States
Employees 4
CEO Punit S. Dhillon

Stock Information

Ticker Symbol EMBI
Stock Exchange US OTC
Sector Healthcare
Industry Biotechnology
Unique Identifier OTCMKTS: EMBI

Description

Emerald Bioscience, a biopharmaceutical company, focuses on the discovery, development, and commercialization of cannabinoid-based therapeutics for unmet medical needs worldwide. The company's lead product candidate is NB1111, which is in preclinical trials for the treatment of glaucoma. It is also developing NB2222, a product candidate in preclinical trials for use in the treatment of various eye diseases, including uveitis, dry eye syndrome, macular degeneration, and diabetic retinopathy; and NB3111, a cannabinoid cocktail in testing for use as an anti-infective agent against various strains of antibiotic resistant bacteria, including methicillin-resistant Staphylococcus aureus. The company was formerly known as Nemus Bioscience, Inc. and changed its name to Emerald Bioscience, Inc. in March 2019. Emerald Bioscience, Inc. was founded in 2012 and is based in San Diego, California.